期刊
FRONTIERS IN MEDICINE
卷 7, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2020.580677
关键词
SARS-CoV-2; infection; COVID-19; biomarker; severity
资金
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [19/02679-7, 17/18199-9, 2018/18230-6, 2019/22448-0, 2019/26928-6]
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES [88887.503842/2020-00]
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [17/18199-9] Funding Source: FAPESP
Common clinical features of patients with Coronavirus disease-2019 (COVID-19) vary from fever, to acute severe respiratory distress syndrome. Several laboratory parameters are reported as indicators of COVID-19 severity. We hereby describe the possible novel severity biomarkers for COVID-19, CD11b+CD33+HLA-DR-CD14+ cells and CD11b+CD33+HLA-DR-CD66b+ cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
